Submission of Standalone Audited financial result for the year ended 31.03.2026.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
KMS Medisurgi Ltd reported audited standalone financial results for FY2025-26. Revenue from operations declined to Rs. 1,220.85 lakhs from Rs. 1,393.86 lakhs in the previous year, representing approximately 12% decline. Profit after tax fell to Rs. 24.55 lakhs from Rs. 43.98 lakhs, a 44% drop. The auditor issued a QUALIFIED OPINION due to two issues: (1) non-compliance with AS-15 for employee benefit calculations as no actuarial valuation was obtained, and (2) incomplete stock record reconciliation with book accounts affecting closing stock valuation of Rs. 253.80 lakhs. Both issues are repetitive qualifications. Cash flow from operations remained positive at Rs. 151.34 lakhs. The company continues to operate under SME exchange exemptions from IND-AS adoption.
The qualified audit opinion and repetitive accounting issues raise concerns about internal controls and financial reporting quality. The 44% decline in net profit combined with auditor qualification may negatively impact investor confidence, though positive operating cash flow and maintained profitability provide some support.